“…Relooking at the current literature for the synthesis of imidazo[1,2- a ]pyridines, we felt interested in dehydrogenetive heteroannulation between 2-aminopyridine and arylketo compounds to afford this heterocycle with an aryl group at C-2 (Scheme ). ,− In this direction, various methods have been developed in conventional media, which include metal-catalyzed C–H functionalization (e.g., Cu(OAc) 2 in dichlorobenzene, CuI in dimethylformamide (DMF), CuI in 1,4-dioxane, CuI–In(OTf) 3 in N -methyl-pyrrolidone (NMP)), in situ α-iodination followed by Ortoleva–King-type reaction in the presence of catalytic or stoichiometric amount of iodine (e.g., I 2 in dimethyl sulfoxide (DMSO), I 2 –NH 4 OAc in CHCl 3 , I 2 –FeCl 3 in chlorobenzene), and few others . Apart from developing new strategies, efforts are also directed toward the development of practical and scalable methods for the synthesis of imidazo[1,2- a ]pyridine-based drug candidates. ,,,, However, these methods have one or more shortcomings like the requirement of dry conditions, use of hazardous organic solvents, Lewis acids, high temperature, and so forth.…”